Thorner 1996 - Once-Daily Subcutaneous GHRH 1-29 in GH-Deficient Children

Journal of Clinical Endocrinology & Metabolism·January 1, 1996

Michael O. Thorner

Summary

Once-daily subcutaneous GHRH(1-29) increased height velocity in children with growth hormone deficiency, supporting sermorelin as a GH-axis therapeutic candidate.

Study Details

Study Design

Open-label multicenter clinical study

Indication

Growth hormone deficiency in children

Intervention

Once-daily subcutaneous GHRH(1-29) / sermorelin

Species

Human

Risk of Bias Assessment

Older clinical study; open-label design